BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kastrup J, Schou M, Gustafsson I, Nielsen OW, Møgelvang R, Kofoed KF, Kragelund C, Hove JD, Fabricius-Bjerre A, Heitman M, Haack-Sørensen M, Lund LD, Johansen EM, Qayyum AA, Mathiasen AB, Ekblond A. Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study. Stem Cells Int 2017;2017:8506370. [PMID: 29056973 DOI: 10.1155/2017/8506370] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Haack-Sørensen M, Johansen EM, Højgaard LD, Kastrup J, Ekblond A. GMP Compliant Production of a Cryopreserved Adipose-Derived Stromal Cell Product for Feasible and Allogeneic Clinical Use. Stem Cells Int 2022;2022:4664917. [PMID: 35769340 DOI: 10.1155/2022/4664917] [Reference Citation Analysis]
2 Konstanty-Kalandyk J, Sadowski J, Kędziora A, Urbańczyk-Zawadzka M, Baran J, Banyś P, Kapelak B, Piątek J. Functional Recovery after Intramyocardial Injection of Adipose-Derived Stromal Cells Assessed by Cardiac Magnetic Resonance Imaging. Stem Cells Int 2021;2021:5556800. [PMID: 33976700 DOI: 10.1155/2021/5556800] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Povsic TJ, Gersh BJ. Stem Cells in Cardiovascular Diseases: 30,000-Foot View. Cells 2021;10:600. [PMID: 33803227 DOI: 10.3390/cells10030600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kamenaga T, Kuroda Y, Nagai K, Tsubosaka M, Takashima Y, Kikuchi K, Fujita M, Ikuta K, Anjiki K, Maeda T, Nakano N, Takayama K, Hashimoto S, Hayashi S, Matsushita T, Niikura T, Kuroda R, Matsumoto T. Cryopreserved human adipose-derived stromal vascular fraction maintains fracture healing potential via angiogenesis and osteogenesis in an immunodeficient rat model. Stem Cell Res Ther 2021;12:110. [PMID: 33541427 DOI: 10.1186/s13287-021-02182-3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Møller-Hansen M, Larsen AC, Toft PB, Lynggaard CD, Schwartz C, Bruunsgaard H, Haack-Sørensen M, Ekblond A, Kastrup J, Heegaard S. Safety and feasibility of mesenchymal stem cell therapy in patients with aqueous deficient dry eye disease. Ocul Surf 2021;19:43-52. [PMID: 33253910 DOI: 10.1016/j.jtos.2020.11.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Juhl M, Christensen JP, Pedersen AE, Kastrup J, Ekblond A. Cryopreservation of peripheral blood mononuclear cells for use in proliferation assays: First step towards potency assays. J Immunol Methods 2021;488:112897. [PMID: 33049298 DOI: 10.1016/j.jim.2020.112897] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Tsubosaka M, Matsumoto T, Sobajima S, Matsushita T, Iwaguro H, Kuroda R. The influence of adipose-derived stromal vascular fraction cells on the treatment of knee osteoarthritis. BMC Musculoskelet Disord 2020;21:207. [PMID: 32252731 DOI: 10.1186/s12891-020-03231-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
8 Hoogduijn MJ, Montserrat N, van der Laan LJW, Dazzi F, Perico N, Kastrup J, Gilbo N, Ploeg RJ, Roobrouck V, Casiraghi F, Johnson CL, Franquesa M, Dahlke MH, Massey E, Hosgood S, Reinders MEJ. The emergence of regenerative medicine in organ transplantation: 1st European Cell Therapy and Organ Regeneration Section meeting. Transpl Int 2020;33:833-40. [PMID: 32237237 DOI: 10.1111/tri.13608] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
9 Mathiasen AB, Qayyum AA, Jørgensen E, Helqvist S, Kofoed KF, Haack-Sørensen M, Ekblond A, Kastrup J. Bone marrow-derived mesenchymal stromal cell treatment in patients with ischaemic heart failure: final 4-year follow-up of the MSC-HF trial. Eur J Heart Fail 2020;22:884-92. [PMID: 31863561 DOI: 10.1002/ejhf.1700] [Cited by in Crossref: 26] [Cited by in F6Publishing: 40] [Article Influence: 8.7] [Reference Citation Analysis]
10 Qayyum AA, Mathiasen AB, Helqvist S, Jørgensen E, Haack-Sørensen M, Ekblond A, Kastrup J. Autologous adipose-derived stromal cell treatment for patients with refractory angina (MyStromalCell Trial): 3-years follow-up results. J Transl Med 2019;17:360. [PMID: 31711513 DOI: 10.1186/s12967-019-2110-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
11 Sciatti E, Dallapellegrina L, Metra M, Lombardi CM. New drugs for the treatment of chronic heart failure with a reduced ejection fraction: What the future may hold. Journal of Cardiovascular Medicine 2019;20:650-9. [DOI: 10.2459/jcm.0000000000000850] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
12 Mazini L, Rochette L, Amine M, Malka G. Regenerative Capacity of Adipose Derived Stem Cells (ADSCs), Comparison with Mesenchymal Stem Cells (MSCs). Int J Mol Sci. 2019;20:2523. [PMID: 31121953 DOI: 10.3390/ijms20102523] [Cited by in Crossref: 86] [Cited by in F6Publishing: 123] [Article Influence: 28.7] [Reference Citation Analysis]
13 Paitazoglou C, Bergmann MW, Vrtovec B, Chamuleau SAJ, van Klarenbosch B, Wojakowski W, Michalewska-Włudarczyk A, Gyöngyösi M, Ekblond A, Haack-Sørensen M, Jaquet K, Vrangbaek K, Kastrup J; SCIENCE Investigators. Rationale and design of the European multicentre study on Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE). Eur J Heart Fail 2019;21:1032-41. [PMID: 30790396 DOI: 10.1002/ejhf.1412] [Cited by in Crossref: 15] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
14 Ghiroldi A, Piccoli M, Cirillo F, Monasky MM, Ciconte G, Pappone C, Anastasia L. Cell-Based Therapies for Cardiac Regeneration: A Comprehensive Review of Past and Ongoing Strategies. Int J Mol Sci 2018;19:E3194. [PMID: 30332812 DOI: 10.3390/ijms19103194] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
15 Litwinowicz R, Kapelak B, Sadowski J, Kędziora A, Bartus K. The use of stem cells in ischemic heart disease treatment. Kardiochir Torakochirurgia Pol 2018;15:196-9. [PMID: 30310400 DOI: 10.5114/kitp.2018.78446] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
16 Bagno L, Hatzistergos KE, Balkan W, Hare JM. Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges. Mol Ther. 2018;26:1610-1623. [PMID: 29807782 DOI: 10.1016/j.ymthe.2018.05.009] [Cited by in Crossref: 93] [Cited by in F6Publishing: 130] [Article Influence: 23.3] [Reference Citation Analysis]